GeoVax Labs Inc
NASDAQ:GOVX

Watchlist Manager
GeoVax Labs Inc Logo
GeoVax Labs Inc
NASDAQ:GOVX
Watchlist
Price: 0.207 USD 21.76% Market Closed
Market Cap: 6.1m USD

EV/EBITDA
Enterprise Value to EBITDA

-0
Current
-0.1
Median
5.9
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-0
=
Enterprise Value
1.1m USD
/
EBITDA
-25.5m USD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
US
GeoVax Labs Inc
NASDAQ:GOVX
Average EV/EBITDA: 40.2
Negative Multiple: -0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 881.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.2
N/A N/A
NL
argenx SE
XBRU:ARGX
58.5
810%
0.1

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-0
2-Years Forward
EV/EBITDA
-0
3-Years Forward
EV/EBITDA
0